Chemed EPS - Earnings per Share 2012-2026 | CHE
Chemed annual and quarterly earnings per share history from 2012 to 2026. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Chemed EPS for the quarter ending March 31, 2026 was $4.84, a 0.41% decline year-over-year.
- Chemed EPS for the twelve months ending March 31, 2026 was $18.35, a 10.53% decline year-over-year.
- Chemed 2025 annual EPS was $18.34, a 7.79% decline from 2024.
- Chemed 2024 annual EPS was $19.89, a 10.93% increase from 2023.
- Chemed 2023 annual EPS was $17.93, a 8.47% increase from 2022.
| Chemed Annual EPS | |
|---|---|
| 2025 | $18.34 |
| 2024 | $19.89 |
| 2023 | $17.93 |
| 2022 | $16.53 |
| 2021 | $16.85 |
| 2020 | $19.48 |
| 2019 | $13.31 |
| 2018 | $12.23 |
| 2017 | $5.86 |
| 2016 | $6.48 |
| 2015 | $6.33 |
| 2014 | $5.57 |
| 2013 | $4.16 |
| 2012 | $4.62 |
| 2011 | $4.10 |
| Chemed Quarterly EPS | |
|---|---|
| 2026-03-31 | $4.84 |
| 2025-12-31 | $5.48 |
| 2025-09-30 | $4.46 |
| 2025-06-30 | $3.57 |
| 2025-03-31 | $4.86 |
| 2024-12-31 | $6.00 |
| 2024-09-30 | $5.00 |
| 2024-06-30 | $4.65 |
| 2024-03-31 | $4.24 |
| 2023-12-31 | $5.91 |
| 2023-09-30 | $4.93 |
| 2023-06-30 | $3.51 |
| 2023-03-31 | $3.58 |
| 2022-12-31 | $4.13 |
| 2022-09-30 | $3.78 |
| 2022-06-30 | $4.40 |
| 2022-03-31 | $4.22 |
| 2021-12-31 | $4.78 |
| 2021-09-30 | $4.55 |
| 2021-06-30 | $3.51 |
| 2021-03-31 | $4.01 |
| 2020-12-31 | $6.95 |
| 2020-09-30 | $4.14 |
| 2020-06-30 | $5.01 |
| 2020-03-31 | $3.38 |
| 2019-12-31 | $3.97 |
| 2019-09-30 | $3.56 |
| 2019-06-30 | $3.08 |
| 2019-03-31 | $2.70 |
| 2018-12-31 | $3.24 |
| 2018-09-30 | $3.06 |
| 2018-06-30 | $3.27 |
| 2018-03-31 | $2.66 |
| 2017-12-31 | $3.30 |
| 2017-09-30 | $2.13 |
| 2017-06-30 | $-1.35 |
| 2017-03-31 | $1.78 |
| 2016-12-31 | $1.93 |
| 2016-09-30 | $1.62 |
| 2016-06-30 | $1.48 |
| 2016-03-31 | $1.45 |
| 2015-12-31 | $1.73 |
| 2015-09-30 | $1.65 |
| 2015-06-30 | $1.55 |
| 2015-03-31 | $1.40 |
| 2014-12-31 | $1.70 |
| 2014-09-30 | $1.39 |
| 2014-06-30 | $1.36 |
| 2014-03-31 | $1.12 |
| 2013-12-31 | $1.28 |
| 2013-09-30 | $0.94 |
| 2013-06-30 | $0.77 |
| 2013-03-31 | $1.17 |
| 2012-12-31 | $1.39 |
| 2012-09-30 | $1.07 |
| 2012-06-30 | $1.10 |
| 2012-03-31 | $1.06 |
| 2011-12-31 | $1.28 |
| 2011-09-30 | $1.04 |
| 2011-06-30 | $0.94 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |